CN102893157A - 前列腺癌的代谢特征 - Google Patents

前列腺癌的代谢特征 Download PDF

Info

Publication number
CN102893157A
CN102893157A CN2010800645336A CN201080064533A CN102893157A CN 102893157 A CN102893157 A CN 102893157A CN 2010800645336 A CN2010800645336 A CN 2010800645336A CN 201080064533 A CN201080064533 A CN 201080064533A CN 102893157 A CN102893157 A CN 102893157A
Authority
CN
China
Prior art keywords
cancer
acid
sample
metabolites
levels
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2010800645336A
Other languages
English (en)
Chinese (zh)
Inventor
A.M.钱奈延
T.拉詹迪兰
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Michigan System
Original Assignee
University of Michigan System
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Michigan System filed Critical University of Michigan System
Publication of CN102893157A publication Critical patent/CN102893157A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57415—Specifically defined cancers of breast
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G01N33/493—Physical analysis of biological material of liquid biological material urine
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57434—Specifically defined cancers of prostate
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
CN2010800645336A 2009-12-22 2010-12-22 前列腺癌的代谢特征 Pending CN102893157A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US28920609P 2009-12-22 2009-12-22
US61/289206 2009-12-22
PCT/US2010/061811 WO2011087845A2 (en) 2009-12-22 2010-12-22 Metabolomic profiling of prostate cancer

Publications (1)

Publication Number Publication Date
CN102893157A true CN102893157A (zh) 2013-01-23

Family

ID=44151645

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2010800645336A Pending CN102893157A (zh) 2009-12-22 2010-12-22 前列腺癌的代谢特征

Country Status (5)

Country Link
US (2) US20110151497A1 (enExample)
EP (1) EP2517022A4 (enExample)
JP (1) JP2013515270A (enExample)
CN (1) CN102893157A (enExample)
WO (1) WO2011087845A2 (enExample)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106770873A (zh) * 2017-01-19 2017-05-31 中国人民解放军第四军医大学 一种膀胱癌诊断标志物及其应用和诊断试剂盒
CN108344830A (zh) * 2017-01-22 2018-07-31 中国科学院大连化学物理研究所 用于诊断前列腺癌的尿样组合标志物及检测试剂盒和方法
CN108414661A (zh) * 2018-03-13 2018-08-17 中国医科大学 一种检测生物样品中氨含量的衍生化气相色谱-质谱方法
KR20190033382A (ko) * 2017-09-21 2019-03-29 연세대학교 산학협력단 대사체 프로파일링을 이용한 유방암의 예후 또는 위험도를 평가하는 방법 및 키트
CN114487217A (zh) * 2022-02-14 2022-05-13 广州市番禺区中心医院 一种区分前列腺癌和良性前列腺增生的标志物及试剂盒
WO2025054293A1 (en) * 2023-09-05 2025-03-13 National Taiwan University Biomarker for prostate cancer

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3812009A1 (en) * 2012-02-23 2021-04-28 Keio University Combined anticancer drug sensitivity-determining marker
KR101462206B1 (ko) * 2013-06-26 2014-11-20 한국과학기술연구원 트립토판 대사 변화를 이용한 위암 진단용 기초 정보 제공 방법
JP6222629B2 (ja) * 2013-08-29 2017-11-01 花王株式会社 排尿障害のバイオマーカー
KR101955430B1 (ko) * 2013-10-11 2019-03-11 주식회사 씨스퀘어 사르코신 대사산물 중 과산화물을 이용한 전립선암 진단 시험지, 그 제조 방법 및 이를 이용한 전립선암 진단에 필요한 정보를 제공하는 방법
BR112017004773B1 (pt) * 2014-09-10 2024-02-27 Fundação Pio Xii Hospital De Câncer De Barretos Cnpj/Mf Biomarcadores para avaliação do câncer de mama
CN115236166A (zh) * 2016-05-29 2022-10-25 深圳市绘云生物科技有限公司 肝病相关生物标志物和其使用方法
WO2017213246A1 (ja) * 2016-06-10 2017-12-14 株式会社日立製作所 尿中代謝物による疾病診断法
JP6280997B1 (ja) * 2016-10-31 2018-02-14 株式会社Preferred Networks 疾患の罹患判定装置、疾患の罹患判定方法、疾患の特徴抽出装置及び疾患の特徴抽出方法
EP3803390B1 (en) * 2018-06-01 2024-05-01 Lewis, Ian Andrew Method for detecting urinary tract infections and sample analysis
IT201800007264A1 (it) * 2018-07-17 2020-01-17 Metodo per la diagnosi in vitro di carcinoma della prostata mediante biomarcatori urinari
KR102405789B1 (ko) * 2018-08-24 2022-06-07 고려대학교 세종산학협력단 키누레닌 경로 대사체를 포함하는 전립선암 진단용 바이오마커 조성물
EP3629021A1 (en) * 2018-09-26 2020-04-01 Euroimmun Medizinische Labordiagnostika AG Diagnosis of a neuroautoimmune disease
KR20210030883A (ko) * 2019-09-10 2021-03-18 고려대학교 세종산학협력단 인돌아민 2,3-이산소화 효소를 포함하는 전립선암 진단용 마커
US20210333280A1 (en) * 2020-04-23 2021-10-28 YatHing Biotechnology Company Limited Methods related to the diagnosis of prostate cancer
US20230384316A1 (en) * 2020-10-20 2023-11-30 Baylor College Of Medicine Multiplex metabolic markers in plasma for early detection of african american prostate cancer
WO2022149487A1 (ja) * 2021-01-07 2022-07-14 住友化学株式会社 前立腺がんの罹患の可能性を検査する方法
CN114324674A (zh) * 2022-01-21 2022-04-12 苏州南医大创新中心 一种精液中与无精子症有关的分子标志物及其检测方法和应用
CN114544812B (zh) * 2022-02-18 2023-06-30 复旦大学附属中山医院 一种代谢组合式标志物在诊断哮喘中的应用
CN116465920B (zh) * 2023-04-03 2023-11-10 汕头大学医学院 用于诊断食管癌的代谢标志物
CN116106535B (zh) * 2023-04-11 2023-08-11 南京品生医学检验实验室有限公司 生物标志物组合在制备乳腺癌预测产品中的应用
DE102023125870A1 (de) * 2023-09-25 2025-03-27 Numares Ag Verwendung eines Markersets für die Diagnostik des Prostatakarzinoms

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6020139A (en) * 1995-04-25 2000-02-01 Oridigm Corporation S-adenosyl methionine regulation of metabolic pathways and its use in diagnosis and therapy
US6866837B2 (en) * 1998-06-05 2005-03-15 Mallinckrodt Inc. Radiolabeled peptides for the diagnosis and treatment of breast and prostate tumors and metastases of such tumors
US7329489B2 (en) * 2000-04-14 2008-02-12 Matabolon, Inc. Methods for drug discovery, disease treatment, and diagnosis using metabolomics
WO2001078652A2 (en) * 2000-04-14 2001-10-25 Metabolon, Inc. Methods for drug discovery, disease treatment, and diagnosis using metabolomics
US20050181375A1 (en) * 2003-01-10 2005-08-18 Natasha Aziz Novel methods of diagnosis of metastatic cancer, compositions and methods of screening for modulators of metastatic cancer
US20070078093A1 (en) * 2003-10-16 2007-04-05 The Administrators Of The Tulane Educational Fund Methods and compositions for treating cancer
US20070055456A1 (en) * 2005-08-31 2007-03-08 Daniel Raftery NMR method for differentiating complex mixtures
WO2007066216A2 (en) * 2005-12-09 2007-06-14 Institut National De La Sante Et De La Recherche Medicale (Inserm) Fatty acids profile correlated to the propensity or risk of breast cancer
CN101454331A (zh) * 2006-03-24 2009-06-10 菲诺梅诺米发现公司 有效用于诊断前列腺癌的生物标记，及其方法
US20090075284A1 (en) * 2006-09-19 2009-03-19 The Regents Of The University Of Michigan Metabolomic profiling of prostate cancer
EP2061899B1 (en) * 2006-09-19 2012-08-29 Metabolon Inc. Biomarkers for prostate cancer and methods using the same
US20090047269A1 (en) * 2007-08-16 2009-02-19 The Regents Of The University Of Michigan Metabolomic cancer targets

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106770873A (zh) * 2017-01-19 2017-05-31 中国人民解放军第四军医大学 一种膀胱癌诊断标志物及其应用和诊断试剂盒
CN106770873B (zh) * 2017-01-19 2019-02-19 中国人民解放军第四军医大学 一种膀胱癌诊断标志物及其应用和诊断试剂盒
CN108344830A (zh) * 2017-01-22 2018-07-31 中国科学院大连化学物理研究所 用于诊断前列腺癌的尿样组合标志物及检测试剂盒和方法
CN108344830B (zh) * 2017-01-22 2020-10-16 中国科学院大连化学物理研究所 用于诊断前列腺癌的尿样组合标志物及检测试剂盒
KR20190033382A (ko) * 2017-09-21 2019-03-29 연세대학교 산학협력단 대사체 프로파일링을 이용한 유방암의 예후 또는 위험도를 평가하는 방법 및 키트
KR102077058B1 (ko) 2017-09-21 2020-02-13 연세대학교 산학협력단 대사체 프로파일링을 이용한 유방암의 예후 또는 위험도를 평가하는 방법 및 키트
CN108414661A (zh) * 2018-03-13 2018-08-17 中国医科大学 一种检测生物样品中氨含量的衍生化气相色谱-质谱方法
CN108414661B (zh) * 2018-03-13 2020-04-21 中国医科大学 一种检测生物样品中氨含量的衍生化气相色谱-质谱方法
CN114487217A (zh) * 2022-02-14 2022-05-13 广州市番禺区中心医院 一种区分前列腺癌和良性前列腺增生的标志物及试剂盒
WO2025054293A1 (en) * 2023-09-05 2025-03-13 National Taiwan University Biomarker for prostate cancer

Also Published As

Publication number Publication date
EP2517022A4 (en) 2013-07-10
JP2013515270A (ja) 2013-05-02
EP2517022A2 (en) 2012-10-31
WO2011087845A2 (en) 2011-07-21
WO2011087845A3 (en) 2011-11-17
US20130261022A1 (en) 2013-10-03
US20110151497A1 (en) 2011-06-23

Similar Documents

Publication Publication Date Title
CN102893157A (zh) 前列腺癌的代谢特征
JP5406187B2 (ja) 前立腺癌の代謝プロファイリング法
US20140051601A1 (en) Metabolomic profiling of cancer
Iglesias-Gato et al. The proteome of primary prostate cancer
Kharaziha et al. Molecular profiling of prostate cancer derived exosomes may reveal a predictive signature for response to docetaxel
Saraon et al. Proteomic profiling of androgen-independent prostate cancer cell lines reveals a role for protein S during the development of high grade and castration-resistant prostate cancer
Xu et al. Quantitative proteomics study of breast cancer cell lines isolated from a single patient: discovery of TIMM17A as a marker for breast cancer
Elzek et al. Proteomics of ovarian cancer: functional insights and clinical applications
Petrova et al. Expression of chloride intracellular channel protein 1 (CLIC1) and tumor protein D52 (TPD52) as potential biomarkers for colorectal cancer
JP5068543B2 (ja) がんに関する診断マーカー
US10768182B2 (en) Method for detecting nucleosomes containing histone modifications and variants
BR112014013082B1 (pt) uso de um aduto nucleossomo-proteína e métodos para detectar a presença de um aduto nucleossomo-proteína
CN106468714A (zh) 一组生物标志物在制备结直肠癌诊断试剂中的用途
Polachini et al. Plasma metabolomics of oral squamous cell carcinomas based on NMR and MS approaches provides biomarker identification and survival prediction
EP2876445A1 (en) Method for in vitro diagnosing and prognosing of triple negative breast cancer recurrence
JP6674889B2 (ja) 前立腺がんに対するバイオマーカー検出における使用のための方法とアレイ
Sun et al. Characterization of the liver tissue interstitial fluid (TIF) proteome indicates potential for application in liver disease biomarker discovery
JP2011512149A (ja) ガンの検出の方法および手法
JP5721628B2 (ja) 癌診断用マーカーとしてのプロテインキナーゼＣα
US20190234952A1 (en) Methods of detecting hypoxia-associate peptides
US7407763B2 (en) Systems and methods for detecting and regulating metastasis
Yuan Identification of Plasma Metabolites Associated with Breast and Ovarian Cancer and Breast Cancer Prognosis
Nimer et al. Untargeted LC-MS/MS-based metabolomics profiling of colorectal cancer cell lines reveals potential hypoxia-associated biomarkers
Bojazyah Comparative proteomic analysis of differentially expressed proteins in metastatic breast cancer cell lines in response to oral hypoglycemic treatment
HK1143418B (en) Metabolomic profiling of prostate cancer

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C05 Deemed withdrawal (patent law before 1993)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20130123